Brief: Scandinavian ChemoTech Gets Order Worth $30,000 For TSE Cancer Treatment Technology
Feb 12 (Reuters) - Scandinavian ChemoTech AB
CMOTECb.ST :
* NEW ORDER RECEIVED FOR THE INNOVATIVE TSE CANCER TREATMENT
TECHNOLOGY
* ORDER FOR USD 30,000 FROM ONE OF ITS LARGEST CLIENTS IN
UNITED
STATES
Source text for Eikon: ID:nWkrbGphMl
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million